Literature DB >> 8364730

Neuropeptide Y and optic chiasm stimulation affect suprachiasmatic nucleus circadian function in vitro.

S Shibata1, R Y Moore.   

Abstract

The retinohypothalamic tract (RHT) is a direct pathway from the retina to the suprachiasmatic nucleus (SCN). Electrical stimulation of the optic nerve or optic chiasm activates the RHT and produces shifts in phase of a circadian rhythm in SCN neuron activity in rat hypothalamic slices in vitro. The phase response curve (PRC) for this effect is very similar to that obtained from administration of light pulses to intact animals maintained in constant darkness. The effect of optic chiasm stimulation is blocked by tetrodotoxin. In addition to the RHT, there is a second entraining pathway, the geniculohypothalamic tract, which arises from neuropeptide Y (NPY)-containing neurons of the intergeniculate leaflet of the lateral geniculate complex. In contrast to optic chiasm stimulation. NPY produces phase shifts in the rhythms of SCN neuron firing rate in vitro with a PRC that similar to that for NPY infusion into the SCN in intact animals as well as that produced by a series of treatments that induce locomotor activity. These results indicate that phase shifts of the circadian rhythm of SCN neuron activity may be produced by activation of two different entraining pathways and that the physiological actions of these pathways on pacemaker function are markedly different.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8364730     DOI: 10.1016/0006-8993(93)91118-c

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  20 in total

1.  Substance p plays a critical role in photic resetting of the circadian pacemaker in the rat hypothalamus.

Authors:  D Y Kim; H C Kang; H C Shin; K J Lee; Y W Yoon; H C Han; H S Na; S K Hong; Y I Kim
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 2.  Exploring spatiotemporal organization of SCN circuits.

Authors:  L Yan; I Karatsoreos; J Lesauter; D K Welsh; S Kay; D Foley; R Silver
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2007

3.  Multiple NPY receptors coexist in pre- and postsynaptic sites: inhibition of GABA release in isolated self-innervating SCN neurons.

Authors:  G Chen; A N van den Pol
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

4.  Geniculohypothalamic GABAergic projections gate suprachiasmatic nucleus responses to retinal input.

Authors:  Lydia Hanna; Lauren Walmsley; Abigail Pienaar; Michael Howarth; Timothy M Brown
Journal:  J Physiol       Date:  2017-04-11       Impact factor: 5.182

5.  NMDA-evoked calcium transients and currents in the suprachiasmatic nucleus: gating by the circadian system.

Authors:  C S Colwell
Journal:  Eur J Neurosci       Date:  2001-04       Impact factor: 3.386

6.  Excitatory mechanisms in the suprachiasmatic nucleus: the role of AMPA/KA glutamate receptors.

Authors:  Stephan Michel; Jason Itri; Christopher S Colwell
Journal:  J Neurophysiol       Date:  2002-08       Impact factor: 2.714

7.  Role for the NR2B subunit of the N-methyl-D-aspartate receptor in mediating light input to the circadian system.

Authors:  L M Wang; A Schroeder; D Loh; D Smith; K Lin; J H Han; S Michel; D L Hummer; J C Ehlen; H E Albers; C S Colwell
Journal:  Eur J Neurosci       Date:  2008-04       Impact factor: 3.386

8.  Neuropeptide Y depresses GABA-mediated calcium transients in developing suprachiasmatic nucleus neurons: a novel form of calcium long-term depression.

Authors:  K Obrietan; A N van den Pol
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

9.  Gastrin releasing peptide and neuropeptide Y exert opposing actions on circadian phase.

Authors:  George J Kallingal; Eric M Mintz
Journal:  Neurosci Lett       Date:  2007-06-08       Impact factor: 3.046

10.  Circadian modulation of melanopsin-driven light response in rat ganglion-cell photoreceptors.

Authors:  Shijun Weng; Kwoon Y Wong; David M Berson
Journal:  J Biol Rhythms       Date:  2009-10       Impact factor: 3.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.